TheStreet: Stock Quotes, Financial Market News, & Investment Advice

Commentary

Little-Known Facts About Roth IRAs

Roth IRA conversions will get a big change next year. Here are details to consider.

Vote in our Poll

Can First Solar Keep Up With the Chinese?

In the face of increasing competition from Chinese solar firms, what will be the fat of First Solar stock in 2010?

Most Commented Story Today

Top Three ETFs for 2010

These ETF picks for the new year highlight three investment themes: inflation protection, dividend-paying equities and green energy.

Videos

Boeing 787 Delays May Not Matter

Best of TSC-TV: The Boeing 787 delays have cost Boeing in the short term but TSC's Ted Reed explains why today's next test flight of the Dreamliner and the move to buy the manufacturing plant in SC are game changers. 12-22-09

Videos

#1 Gold Stock to Avoid

NEW YORK (TheStreet) -- Don Dion, TSC contributor, reveals his price target on gold and the one stock he urges investors to avoid.

Videos

Floor Favorites for 2010

Traders on the floor of the New York Stock Exchange share their favorite sectors for next year.

Stanley Bing

What I Want for Christmas

Stanley Bing has been very good this year. So come on, Santa, cough up the loot (and some peace on earth).

Best in Class Business

Exxon Prepares for the Future: Best in Class

The biggest member of Big Oil has become an energy company, as CEO Rex Tillerson makes the largest push toward diversification in Exxon's history.

Between the Lines
Dave's Daily
Dave's Daily: The Beat Goes On

I don't think anything is capable of stopping bulls from pushing markets higher right now.

Banks & Insurers
Fannie, Freddie CEOs to Earn $4M-$6M in '09

The top executives at Fannie Mae and Freddie Mac will each earn between $4 million and $6 million in 2009, according to SEC filings Thursday.

Technology
Six Best Smartphones of 2009

Before you upgrade to a new smartphone, read our guide to the year's best models.

Biotech
Medicines Co. Buys Heart Drug From Pfizer: BioBuzz

Artery-clearing drug, once thought to be potential blockbuster, is sold at a steep discount.

ETFs
#1 Gold Stock to Avoid

NEW YORK (TheStreet) -- Don Dion, TSC contributor, reveals his price target on gold and the one stock he urges investors to avoid.

Earnings
Finish Line Jumps on Surprise Profit

Finsih Line shares soar after the company posts a surprise profit.

IPOs
Poll Swings and Misses on IPOs

In a disappointing week for IPOs, TheStreet users miss the mark in attempting to peg the most successful deal.

Mergers & Acquisitions
Novartis Buying U.S. Maker of Heart Drug

Novartis is buying privately held U.S. biopharmaceutical firm Corthera for $120 million, gaining exclusive rights to Relaxin, an experimental heart drug.

TheStreet Ratings
Stantec, Alpha Natural Lead High-Flying Stocks

Stantec, Century Aluminum and Alpha Natural Resources hit 52-week highs yesterday.

Winners & Losers
'Fast Money' Recap: Sell UnitedHealth

Guy Adami says investors should have bought the stock when the rhetoric on UNH was negative. Now it's time to sell.

Try RealMoney Free Trial Now

Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,520.10 1,126.48 2,285.69 38.07
Oil *
76.10
UP
53.66
UP
5.89
UP
16.05
UP
0.59
10 Yr
3.81%
SPDR Gold
108.36
+0.51%
+0.53%
+0.71%
+1.57%
Data delayed 20 minutes

More From TheStreet

Latest Headlines
  • Top Rated Stocks from TheStreet Ratings
  • NEW: Market Data Section
  • Find returns with the Dividend Calendar

Brokerage Partners

TheStreet Premium Services

All Services

Special Advertising Features